Drugs / RTVP-1 Gene
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00403221 | Aug 2006 → Apr 2011 | prostate neoplasm | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTVP-1 Gene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00403221 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “in situ RTVP-1 gene therapy” NCT00403221 ↗ |
| Route | Other | “We propose here an intraprostatic injection of RTVP-1 in an adenoviral vector 4-6 weeks prior to radical prostatectomy” NCT00403221 ↗ |